Biologically Active Small Molecules

A fluorinated fucose analog that can be metabolized inside the cell to a substrate-based inhibitor of fucosyltransferases.

A fluorinated fucose analog that can be metabolized inside the cell to a substrate-based inhibitor of fucosyltransferases.

A fluorinated fucose analog that can be metabolized inside the cell to a substrate-based inhibitor of fucosyltransferases.

An inactive metabolite of artemisinin.

An inactive metabolite of artemisinin.

An inactive metabolite of artemisinin.

A non-metabolizable glucose analog widely used as a glycolytic inhibitor to study metabolic activity with related to cancer, neurodegeneration, calorie restriction, and aging.

A non-metabolizable glucose analog widely used as a glycolytic inhibitor to study metabolic activity with related to cancer, neurodegeneration, calorie restriction, and aging.

A non-metabolizable glucose analog widely used as a glycolytic inhibitor to study metabolic activity with related to cancer, neurodegeneration, calorie restriction, and aging.

A non-metabolizable glucose analog widely used as a glycolytic inhibitor to study metabolic activity with related to cancer, neurodegeneration, calorie restriction, and aging.

A derivative of 2-DG that is produced in mammalian cells by the action of hexokinase accumulation of 2-DG6P in cells can inhibit glycolysis, leading to cell death.

A derivative of 2-DG that is produced in mammalian cells by the action of hexokinase accumulation of 2-DG6P in cells can inhibit glycolysis, leading to cell death.